SPATS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.733800E-01
Normal-vs-Stage2
8.555600E-01
Normal-vs-Stage3
4.882400E-01
Normal-vs-Stage4
6.716600E-01
Stage1-vs-Stage2
7.122000E-01
Stage1-vs-Stage3
3.029400E-01
Stage1-vs-Stage4
9.795800E-01
Stage2-vs-Stage3
3.070600E-01
Stage2-vs-Stage4
7.369000E-01
Stage3-vs-Stage4
3.487600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.622200E-01
Normal-vs-AfricanAmerican
7.578800E-01
Normal-vs-Asian
5.243800E-01
Caucasian-vs-AfricanAmerican
8.515000E-01
Caucasian-vs-Asian
1.110580E-01
AfricanAmerican-vs-Asian
2.799200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.692800E-01
Normal-vs-Female
8.166200E-01
Male-vs-Female
8.165000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.613000E-01
Normal-vs-Age(41-60Yrs)
3.189600E-01
Normal-vs-Age(61-80Yrs)
9.641800E-01
Normal-vs-Age(81-100Yrs)
9.808600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.706800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.744600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.300600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.158100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.014100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.958400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.033200E-01
Normal-vs-Daily Drinker
5.582600E-01
Normal-vs-Weekly Drinker
8.271600E-01
Normal-vs-Occasional Drinker
5.139000E-01
Normal-vs-Social Drinker
5.506200E-01
Non Drinker-vs-Daily Drinker
8.399800E-01
Non Drinker-vs-Weekly Drinker
2.140600E-01
Non Drinker-vs-Occasional Drinker
3.550400E-02
Non Drinker-vs-Social Drinker
1.771870E-02
Daily Drinker-vs-Weekly Drinker
2.648600E-01
Daily Drinker-vs-Occasional Drinker
4.479500E-02
Daily Drinker-vs-Social Drinker
3.601600E-02
Weekly Drinker-vs-Occasional Drinker
3.418600E-01
Weekly Drinker-vs-Social Drinker
6.497200E-01
Occasional Drinker-vs-Social Drinker
4.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.291000E-01
Normal-vs-Grade 2
8.121800E-01
Normal-vs-Grade 3
8.206200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.242800E-01
Grade 1-vs-Grade 3
5.731400E-01
Grade 1-vs-Grade 4
5.291000E-01
Grade 2-vs-Grade 3
8.673200E-01
Grade 2-vs-Grade 4
8.121800E-01
Grade 3-vs-Grade 4
8.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.559400E-01
Normal-vs-NonDiabetic
8.267000E-01
Diabetic-vs-NonDiabetic
3.922600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.969600E-01
Normal-vs-NoPancreatitis
8.421400E-01
Pancreatitis-vs-NoPancreatitis
5.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.207200E-01
Normal-vs-N1
8.113400E-01
N0-vs-N1
9.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.279800E-01
Normal-vs-TP53-NonMutant
2.312200E-01
TP53-Mutant-vs-TP53-NonMutant
9.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
